Inflammatory bowel disease of the elderly

Frequently asked questions (FAQs)

Seymour Katz, Darrell S. Pardi

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The growing recognition of the older inflammatory bowel disease (IBD) patient is heightened by the entry of the 77.2 million baby boomers who will turn 65 beginning of 2011. It is anticipated that this will occur at a rate of 10,000 per day or 4 million per year for the next 19 years. The management of IBD in this population is complex because of problems with co-morbidities, polypharmacy, impaired mobility, and cognition, as well as difficult social and financial issues. This review focuses on the older IBD patient's unique concerns and provides guidance in their diagnosis and management.

Original languageEnglish (US)
Pages (from-to)1889-1897
Number of pages9
JournalAmerican Journal of Gastroenterology
Volume106
Issue number11
DOIs
StatePublished - Nov 2011

Fingerprint

Inflammatory Bowel Diseases
Polypharmacy
Cognition
Morbidity
Population

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Inflammatory bowel disease of the elderly : Frequently asked questions (FAQs). / Katz, Seymour; Pardi, Darrell S.

In: American Journal of Gastroenterology, Vol. 106, No. 11, 11.2011, p. 1889-1897.

Research output: Contribution to journalArticle

Katz, Seymour ; Pardi, Darrell S. / Inflammatory bowel disease of the elderly : Frequently asked questions (FAQs). In: American Journal of Gastroenterology. 2011 ; Vol. 106, No. 11. pp. 1889-1897.
@article{c609cfd9005a4e81ac4e821f0a65e641,
title = "Inflammatory bowel disease of the elderly: Frequently asked questions (FAQs)",
abstract = "The growing recognition of the older inflammatory bowel disease (IBD) patient is heightened by the entry of the 77.2 million baby boomers who will turn 65 beginning of 2011. It is anticipated that this will occur at a rate of 10,000 per day or 4 million per year for the next 19 years. The management of IBD in this population is complex because of problems with co-morbidities, polypharmacy, impaired mobility, and cognition, as well as difficult social and financial issues. This review focuses on the older IBD patient's unique concerns and provides guidance in their diagnosis and management.",
author = "Seymour Katz and Pardi, {Darrell S.}",
year = "2011",
month = "11",
doi = "10.1038/ajg.2011.271",
language = "English (US)",
volume = "106",
pages = "1889--1897",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Inflammatory bowel disease of the elderly

T2 - Frequently asked questions (FAQs)

AU - Katz, Seymour

AU - Pardi, Darrell S.

PY - 2011/11

Y1 - 2011/11

N2 - The growing recognition of the older inflammatory bowel disease (IBD) patient is heightened by the entry of the 77.2 million baby boomers who will turn 65 beginning of 2011. It is anticipated that this will occur at a rate of 10,000 per day or 4 million per year for the next 19 years. The management of IBD in this population is complex because of problems with co-morbidities, polypharmacy, impaired mobility, and cognition, as well as difficult social and financial issues. This review focuses on the older IBD patient's unique concerns and provides guidance in their diagnosis and management.

AB - The growing recognition of the older inflammatory bowel disease (IBD) patient is heightened by the entry of the 77.2 million baby boomers who will turn 65 beginning of 2011. It is anticipated that this will occur at a rate of 10,000 per day or 4 million per year for the next 19 years. The management of IBD in this population is complex because of problems with co-morbidities, polypharmacy, impaired mobility, and cognition, as well as difficult social and financial issues. This review focuses on the older IBD patient's unique concerns and provides guidance in their diagnosis and management.

UR - http://www.scopus.com/inward/record.url?scp=84860403711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860403711&partnerID=8YFLogxK

U2 - 10.1038/ajg.2011.271

DO - 10.1038/ajg.2011.271

M3 - Article

VL - 106

SP - 1889

EP - 1897

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 11

ER -